Filing Flows › Codexis (CDXS) › Stock forecast & fair value
Codexis (CDXS) stock forecast and fair value
Codexis (CDXS) trades at $1.41. 7 analysts' median price target is $5.00 (+255%), from $2.00 to $11.00. Across 14 valuation methods the middle fair value is $1.47 (+4%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/Sales vs peers | $0.91 | $1.58 | $2.29 | +12% |
| EV/Sales vs peers, weighted | $1.03 | $1.90 | $2.32 | +35% |
| Residual income | −$0.23 | −$0.23 | −$0.24 | -116% |
| Analysts' price targets | $2.00 | $6.14 | $11.00 | +336% |
| Path-to-margin DCF | $0.80 | $1.45 | $2.10 | +3% |
| Path-to-margin DCF, dilution-adjusted | $0.79 | $1.45 | $2.10 | +3% |
| Exit-multiple (venture) method | $1.21 | $1.87 | $3.90 | +32% |
| EV/Sales vs Rule of 40 (all-company fit) | $0.73 | $1.73 | $4.48 | +23% |
| Survival-weighted value | $0.32 | $0.39 | $0.45 | -73% |
| Stage-weighted value (pre-profit / high growth) | $0.80 | $1.39 | $2.52 | -1% |
Codexis' latest quarter
Codexis, Q2 2026: revenue $14.9M (-3% year over year), operating margin -75.3%, net loss $12.0M, operating cash flow −$9.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CDXS stock?
The median of 7 analysts' 12-month targets is $5.00, +255% from $1.41; the range is $2.00 to $11.00. The average rating is none.
What is Codexis' fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between −$0.23 and $6.14, with a middle value of $1.47 against a price of $1.41. Each method's assumptions are on the page.
Does Codexis usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is CDXS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.